Common questions about Artiss (FAQ)
Q: Does Artiss contain steroids?
Artiss is a fibrin sealant. According to the official product composition, its active components are human Fibrinogen, human Thrombin, synthetic Aprotinin, and Calcium Chloride. Steroids are not listed as an active component in this formulation.
Q: What is the expected duration of effect from Artiss?
Once Artiss is applied, the fibrin matrix it forms is designed to provide localized adherence and mechanical support. This matrix is eventually broken down and absorbed by the body through natural healing processes called fibrinolysis and phagocytosis. Aprotinin is included in the formula specifically to delay this breakdown process.
Q: Does Artiss have any reported interactions with common blood thinners?
Because Artiss is applied topically during surgery and is not intended to be injected into the circulatory system, it does not achieve systemic levels. For this reason, formal studies on pharmacokinetic interactions with systemic medicines like blood thinners have generally not been performed. Its topical use suggests compatibility with the systemic use of common anticoagulants.
Q: Are there any food or drink restrictions when using Artiss?
Regulatory documents indicate there are no known drug-food or drug-herb interactions associated with Artiss. This is consistent with its application as a topical sealant that is not absorbed into the bloodstream.
Q: Is it normal to feel a stinging sensation after Artiss is applied?
A stinging or burning sensation at the application site has been reported rarely as a sign of undesirable effects or possible hypersensitivity reactions, according to official product information. If any unusual sensation occurs, the healthcare team is prepared to address the situation.
Q: What happens if Artiss is exposed to light?
Official guidelines emphasize that Artiss must be stored protected from light to maintain its stability and quality. Protecting the product is necessary to maintain its quality before administration, as exposure may compromise its function.
Q: Is Artiss the same as Tisseel?
Both Artiss and Tisseel are types of fibrin sealants, but they are different product formulations. Artiss is specifically characterized as a 'Slow Set' formulation. This means it contains a lower concentration of Thrombin to deliberately slow the setting time, giving the surgeon more time for precise tissue positioning during the procedure.
Q: How long does the body take to break down Artiss?
The Artiss matrix, once set, is eventually metabolized by the body's natural processes. It is absorbed over time, similar to how the body naturally breaks down its own fibrin clots. The speed of this process is delayed by the included Aprotinin component, which protects the seal from premature dissolution.
Q: Can Artiss interact with herbal supplements?
Since Artiss is applied topically and does not enter the bloodstream at systemic levels, formal studies have not been conducted to evaluate interactions with herbal supplements. The primary interaction concerns listed in official documents are limited to local chemical incompatibilities.
Q: Are there any long-term effects of using Artiss that are documented?
The active components of Artiss are designed to be broken down and absorbed by the body over time. Regulatory documents detailing the safety profile primarily focus on adverse reactions observed during and shortly after the surgical procedure. The official labeling does not contain explicit data on very long-term effects extending many years after the application.
Q: What if the Artiss preparation looks cloudy or discolored?
The thawed components of Artiss are expected to be colorless or pale yellow and range from clear to slightly turbid. If the product appears significantly discolored, contains foreign particles, or looks otherwise compromised, a healthcare professional should be informed before application.
Q: Do studies support the use of Artiss in emergency settings?
The indications for Artiss describe its use in procedures such as securing skin grafts and tissue flaps during specialized surgeries. Official documents state Artiss is not indicated for the treatment of massive or rapid (brisk) arterial or venous bleeding.
Q: What should be done if Artiss is accidentally sprayed on an area it wasn't intended for?
The regulatory guidance provided for healthcare professionals focuses on the proper application technique and managing adverse reactions. If an allergic or hypersensitivity reaction is observed, the team is instructed to discontinue administration and, if medically feasible, remove the set product from the surgical field.
Q: Can Artiss cause nerve damage?
While rare, regulatory reports for this class of product have included adverse events such as paralysis or compression-related complications. These events are often reported in connection with the overall surgical context, or the use of fibrin sealant in confined spaces.
Q: Can Artiss be used in patients with known allergies to bovine proteins?
Artiss contains synthetic Aprotinin, which is structurally similar to bovine Aprotinin. Because of this similarity, official labeling notes that potential risks must be evaluated by a healthcare professional in patients with known allergies to bovine proteins.
Q: Is Artiss biodegradable?
Yes, Artiss is biodegradable. The fibrin matrix it creates is chemically similar to a natural blood clot, which means the body can break it down and fully absorb it over time using normal biological processes like fibrinolysis.
Q: Is there a patient information leaflet (PIL) available for Artiss?
Yes, regulatory requirements in many regions mandate the availability of official patient information, such as a Patient Information Leaflet (PIL) or Medication Guide. These documents summarize important safety and usage details and can typically be provided by the healthcare provider.
Q: Do regulatory bodies classify Artiss as a drug or a medical device?
Artiss is classified as a Biologic Product in the United States and is regulated under a Biologics License Application (BLA). In Europe, it is categorized as a medicine that acts as a tissue adhesive agent and coagulation modifier.
Q: What are the general expectations about the duration of the surgical procedure when Artiss is used?
Artiss has a very short setting time, requiring only a few minutes of gentle compression. Therefore, its application only represents a brief step in the overall surgery. The total duration of the procedure is dependent on the complexity of the underlying surgical work, not the use of the sealant itself.
Q: What makes Artiss different from fibrin sealants that use autologous blood?
Artiss is classified as an 'allogeneic' product because its components are derived from pooled human plasma collected from multiple donors. Autologous fibrin sealants, in contrast, are prepared using the patient's own blood just before the procedure.
Q: Is there a maximum amount of Artiss that can be used in one procedure?
The dose of Artiss is individualized, meaning the amount used depends on the size of the area being treated rather than a fixed standard dose. While the label describes how much volume covers a certain surface area, it does not state a fixed, absolute maximum volume for all surgical procedures.
Q: What kind of pain medication can be used after a procedure involving Artiss?
Official information does not specify restrictions on systemic pain medications (like oral analgesics). Clinical evidence suggests that using Artiss for graft fixation may be associated with a reduced need for certain pain medications immediately following the operation.
Q: Does Artiss contain any animal-derived components?
The active components include human Fibrinogen, human Thrombin, and synthetic Aprotinin. However, official warnings note a potential for cross-reactivity in patients allergic to bovine proteins, which requires careful evaluation by the treating physician.
Q: How does the freezing process affect the Artiss product before use?
Artiss is kept deep-frozen to ensure its protein components remain stable and potent. It must be thawed and warmed to a specific temperature (33^circC to 37^circC) before it can be applied. The product must never be re-frozen once thawed, as this could negatively affect its function.
